Objective: The present study has been conducted to investigate the role of plasma homocysteine on neonatal birth weight. 
Introduction :
The period of intrauterine growth and development is one of the most vulnerable periods in the human life cycle. The weight of the infant at birth is a powerful predictor of infant growth and survival, and is dependent on maternal health and nutrition during pregnancy. In developing countries, the majority of low birth-weight (LBW) infants because of intrauterine growth retardation (IUGR) are born small at term (> 37 weeks of gestation). Low birth weight leads to an impaired growth of the infant with its consequent risks of u higher .mortalify rate, increased morbidity', impaired mental developmenf, and the risk of chronic adult disease. Infants who weigh 2,000-2,499 g at 1n6 [BSMMU J 201s ; 6 (2) : ] t6-120J birth have a four-fold higher risk of neonatal death than those who weigh 2, 499 
